par Baxevanis, Constantin N;Sotiropoulou, Panagiota 
;Sotiriadou, Nectaria N;Papamichail, Michael
Référence Cancer immunology and immunotherapy, 53, 3, page (166-175)
Publication Publié, 2004-03
;Sotiriadou, Nectaria N;Papamichail, MichaelRéférence Cancer immunology and immunotherapy, 53, 3, page (166-175)
Publication Publié, 2004-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Baxevanis, Constantin N; Sotiropoulou, Panagiota; Sotiriadou, Nectaria N; Papamichail, Michael |
| Informations sur la publication: | Cancer immunology and immunotherapy, 53, 3, page (166-175) |
| Statut de publication: | Publié, 2004-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
| Cancer Vaccines -- immunology | |
| Humans | |
| Neoplasms -- immunology -- therapy | |
| Receptor, erbB-2 -- immunology -- physiology | |
| Signal Transduction | |
| T-Lymphocytes, Cytotoxic -- immunology | |
| Vaccination | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0340-7004 |
| info:doi/10.1007/s00262-003-0475-7 | |
| info:pmid/14685781 |
